erythrosine has been researched along with Communicable Diseases in 2 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 51 adult patients undergoing living donor liver transplantation (OLT), immunosuppressive drugs were dosed on the basis of immune monitoring by the MLR assay (optimized protocol: group O)." | 1.38 | Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients. ( Ide, K; Ishiyama, K; Ohdan, H; Onoe, T; Tanaka, Y; Tashiro, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, Y | 1 |
| Tashiro, H | 1 |
| Onoe, T | 1 |
| Ide, K | 1 |
| Ishiyama, K | 1 |
| Ohdan, H | 1 |
| Valor, L | 1 |
| Sarmiento, E | 1 |
| Navarro, J | 1 |
| Gallego, A | 1 |
| Fernandez-Yañez, J | 1 |
| Fernandez-Cruz, E | 1 |
| Carbone, J | 1 |
2 other studies available for erythrosine and Communicable Diseases
| Article | Year |
|---|---|
Optimization of immunosuppressive therapy based on a multiparametric mixed lymphocyte reaction assay reduces infectious complications and mortality in living donor liver transplant recipients.
Topics: Acute Disease; Adult; Bacterial Infections; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; | 2012 |
Evaluation of lymphoproliferative responses by carboxy fluorescein succinimidyl ester assay in heart recipients with infections.
Topics: Adult; Aged; Anti-Infective Agents; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8-Positive T | 2012 |